Pharma trade, UAB Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 675,900 |
| 267,154 |
| 91,333 |
| 77,701 |
| 30,712 |
| 13.51 |
| 11.50 |
| 80,201 |
| 135,962 |
| 216,163 |
| 0 |
| 2024 |
|---|
| 5,063,200 |
| 1,687,733 |
| 114,711 |
| 97,504 |
| 32,501 |
| 26.45 |
| 1.93 |
| 177,705 |
| 600,757 |
| 778,462 |
| 0 |
| 2025 |
|---|
| 3,688,850 |
| 1,229,617 |
| 119,792 |
| 100,456 |
| 33,485 |
| 21.21 |
| 2.72 |
| 278,162 |
| 1,127,864 |
| 0 |
| 1,406,026 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 3,688,850 |
| 1,229,617 |
| 119,792 |
| 100,456 |
| 33,485 |
| 21.21 |
| 2.72 |
| 278,162 |
| 1,127,864 |
| 0 |
| 1,406,026 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
3,688,850 €-27 % *
Sales per employee (€)
1,229,617 €-27 % *
Profit before tax (€)
119,792 €4 % *
Net Profit (€)
100,456 €3 % *
Profit per employee (€)
33,485 €3 % *
Total profitability (%)
21.21 %-19.81 % *
Net profitability (%)
2.72 %40.93 % *
Equity (€)
278,162 €57 % *
Amounts Payable And Liabilities (€)
1,127,864 €88 % *
Non-current Assets (€)
0 €-100 % *
CurrentAssets (€)
1,406,026 €- *
